Solid Biosciences
SLDB
76 hedge funds and large institutions have $878M invested in Solid Biosciences in 2018 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 32 increasing their positions, 12 reducing their positions, and 8 closing their positions.
167% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 12
150% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 8
42% more capital invested
Capital invested by funds: $616M → $878M (+$262M)
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
19% more funds holding
Funds holding: 64 → 76 (+12)
0.24% more ownership
Funds ownership: 3.26% → 3.5% (+0.24%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$21.6M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$13.8M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.7M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$12.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$10.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$17.3M |
| 2 |
DM
Deerfield Management
New York
|
-$6.39M |
| 3 |
JP Morgan Chase
New York
|
-$5.75M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$4.61M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$4.29M |
SLDB Hedge Fund Activity: Q3 2018 in Review
76 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Solid Biosciences (SLDB) for Q3 2018, worth a combined $878M — up 42% from $616M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new SLDB positions and 8 closed out — a net gain of 12 holders — while 32 added to existing stakes and 12 trimmed.
The largest buyer was Janus Henderson Group, opening a new position worth an estimated $21.6M. The largest seller was RTW Investments, cutting an estimated $17.3M.
- 76 institutional investors held Solid Biosciences (SLDB) as of Q3 2018, up from 64 in Q2 2018.
- Funds reported $878M of Solid Biosciences stock for Q3 2018, up 42% quarter-over-quarter.
- 20 funds opened new Solid Biosciences positions in Q3 2018 and 8 closed out, a net change of +12 holders.
- The largest Solid Biosciences buyer in Q3 2018 was Janus Henderson Group, an estimated $21.6M added.
- The largest Solid Biosciences seller in Q3 2018 was RTW Investments, an estimated $17.3M sold.
Based on aggregated 13F filings for Q3 2018.